Enhancing the efficacy of siRNA Antibody Oligonucleotide Conjugates (AOCs) through chemical design
Oliver G. Hayes, Julia Rädler, E. Filipiak, Tomasz Czapik, Samantha Roudi, Miina Ojansivu, Hema Saranya Ilamathi, Antonin Marquant, Yanjie Huang, Oscar P. B. Wiklander, Rula Zain, Małgorzata Honcharenko, Samir EL Andaloussi
This study shows that chemical modifications to siRNA and linkers in AOCs can improve potency and tissue targeting while allowing higher payload loading.
bioRxiv · Sep 23, 2026 · PreprintBiochemistry